Φορτώνει......
Safety comparison of additives in antiglaucoma prostaglandin (PG) analog ophthalmic formulations
PURPOSE: To investigate the safety of five types of antiglaucoma prostaglandin analog ophthalmic formulations, and to clarify their differences in accordance with contained additives (preservatives and surface-active agents). METHODS: The following five types of ophthalmic solutions and three types...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2013
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3601024/ https://ncbi.nlm.nih.gov/pubmed/23515900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S40147 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|